|
|
| Outsourcing the development and manufacture of your novel therapeutic demands advanced consideration to ensure the timely and cost-effective completion of your project. Outsourced Pharma is helping address these difficulties. The Outsourced Pharma Capacity Update (OPCU), a free interactive digital event, convenes the industry's foremost CDMOs to provide up-to-date and direct insights into their available capacity and services, alongside specific facility and equipment updates. Discover the July 2024 event’s presenting sponsors in this newsletter and learn how they are best suited to help you to navigate the path to approval and commercialization. These short, digestible presentations give you an inside look at the available capacity of industry suppliers, all from the comfort of your desk. And we've expanded! Our PARTNER WEEK format offers an extended schedule and sessions grouped by capability for an ultra-convenient way to see partner capacities related to your specific outsourcing requirements. Find the right development and manufacturing partner at the upcoming OPCU in October 2024. Registration is free at the links below. - Monday, October 21, 2024 - ADC
- Tuesday, October 22, 2024 - Large Molecule Drug Substance
- Wednesday, October 23, 2024 - Small Molecule
- Thursday, October 24, 2024 - Cell & Gene Therapy
- Friday, October 25, 2024 - Fill/Finish
|
|
|
|
Ajinomoto Bio-Pharma Services | Review our range of offerings including our high speed, multi-purpose fill finish line for vials, syringes, and cartridges located in our manufacturing facilities in San Diego, CA. | Request Information | Ajinomoto Bio-Pharma Services |
|
|
|
Mycenax | Our capabilities include filling vials (liquid or lyophilized), pre-filled syringes (PFS), and cartridge product types, supporting batch sizes of 1,000 to 100,000 vials and up to 120 batches annually. | Request Information | Mycenax |
|
|
|
Comprehensive Cell Solutions | In addition to immediate capacity for Draw-to-Thaw™ services in New York, NY and Louisville, KY, we have openings for process and analytical development work in its Houston, TX facility. | Request Information | Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises |
|
|
VintaBio | VintaBio has created open capacity for AAV clinical manufacturing through its streamlined VintaProcess platform which is an intensified adherent AAV process with very low impurities. | Request Information | VintaBio |
|
|
Andelyn Biosciences | To address the challenges that accompany AAV manufacturing, Andelyn uses a combination of reductionist and holistic approaches to perform end-to-end optimization for its platform. | Request Information | Andelyn Biosciences |
|
|
Kincell Bio | Kincell Bio is a trusted manufacturing services partner for cell therapy companies, providing expert services including access to CMC development and clinical manufacturing for cell therapy. | Request Information | Kincell Bio |
|
|
|
Biocentriq | Learn about BioCentriq's state-of-the-art facilities, established track record in GMP drug product release, and customized solutions supported by a seasoned team with strong commitment to quality. | Request Information | BioCentriq |
|
|
Alcami | Alcami offers method development, method validation and QC testing, as well as R&D testing support, leveraging our company’s extensive expertise in various testing platforms. | Request Information | Alcami |
|
|
WuXi Advanced Therapies | Learn how our expert and experienced team in Philadelphia supports cell therapy and viral vector production across a variety of modalities and stages of clinical and commercial manufacturing. | Request Information | WuXi Advanced Therapies |
|
|
Cellistic | Explore the latest insights and challenges in the cell therapy space, and learn how Cellistic overcomes these challenges with iPSC, focusing on regulatory strategies and cutting-edge capabilities. | Request Information | Cellistic |
|
|
|
|
| Streamline your search for the ideal CDMO partner at the October 2024 OPCU virtual event! Ease the burden of a prolonged vetting process and connect with multiple CDMOs in a single day to find the partner best suited for your project. Register here for the virtual event! For your convenience, OPCU is grouped by capability type. You can register for the session(s) highlighting the CDMOs equipped to meet your company's development and manufacturing needs. - Monday, October 21, 2024 - ADC | Free Registration
- Tuesday, October 22, 2024 - Large Molecule Drug Substance | Free Registration
- Wednesday, October 23, 2024 - Small Molecule | Free Registration
- Thursday, October 24, 2024 - Cell & Gene Therapy | Free Registration
- Friday, October 25, 2024 - Fil/Finish | Free Registration
|
|
|
